Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Bero to Drug Evaluation

This is a "connection" page, showing publications Lisa Bero has written about Drug Evaluation.

 
Connection Strength
 
 
 
0.848
 
  1. Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ. 2012 Jan 03; 344:d7202.
    View in: PubMed
    Score: 0.419
  2. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996 Mar 01; 124(5):485-9.
    View in: PubMed
    Score: 0.140
  3. Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care. 1996; 12(2):209-37.
    View in: PubMed
    Score: 0.138
  4. Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. JAMA. 1994 Jul 13; 272(2):101-4.
    View in: PubMed
    Score: 0.125
  5. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ. 2012 Aug 16; 345:e5155.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)